Inflammation contributes to renal ischemia reperfusion (I/R) injury, potentially causing renal dysfunction. The inflammatory infiltrate mainly consists of neutrophils, which are deleterious for the renal tissue. Because CD44 is expressed by neutrophils and is rapidly upregulated by capillary endothelial cells after I/R injury, it was hypothesized that CD44 might play an important role in the development of I/R injury. This study showed that rapid CD44 upregulation on renal capillary endothelial cells mediates neutrophil recruitment to the postischemic tissue. Hence, CD44 deficiency led to decreased influx of neutrophils regardless of comparable levels in chemotactic factors expressed in the kidney. The reduced influx of neutrophils was associated with preserved renal function and morphology. Adoptive transfer experiments of labeled neutrophils revealed that endothelial CD44 rather than neutrophil CD44 mediates neutrophil migration. Activation of neutrophils increased cell-surface expression of hyaluronic acid (HA). Altogether, a novel mechanism in the recruitment of neutrophils that involves interaction of endothelial CD44 and neutrophil HA was found. Either blocking endothelial CD44 or removal of neutrophil HA decreased rolling and adhesion of neutrophils. Administration of anti-CD44 to mice reduced the influx of neutrophils into the postischemic tissue, associated with renal function preservation. Therefore, anti-CD44 -based therapies may contribute to prevent or reduce renal I/R injury.
R enal injury as a result of ischemia reperfusion (I/R) is a major clinical problem and is the most common cause of acute renal failure after renal transplantation, shock, sepsis, and renal artery stenosis. For patients in shock, acute tubular necrosis is associated with a mortality rate of approximately 50%, and little has changed in the past 40 yr (1). Treatment of I/R injury is still only supportive. Therefore, development of therapeutic interventions to prevent or reduce renal tissue injury after I/R remains the focus of research.
CD44 is a family of type I transmembrane glycoproteins with a wide tissue distribution, including expression on leukocytes and epithelial and endothelial cells. CD44 family glycoproteins are encoded by a single gene that consists of 19 exons. By alternative splicing, different isoforms are generated (2) (3) (4) (5) . These isoforms have been implicated in many physiologic and pathologic processes, such as cell-cell and cell-matrix interaction, leukocyte extravasation, wound healing/scarring, cell migration, lymphocyte activation, and binding/presentation of growth factors (6 -9) . All isoforms contain a hyaluronic acid (HA) and osteopontin binding site, which are the major ligands of CD44 (7, 10) .
Little is known about the physiologic role of CD44 in the kidney after renal injury. Under normal conditions, CD44 is hardly expressed in the kidney except in passenger leukocytes. In inflammatory renal diseases, CD44 expression is markedly enhanced in glomeruli and on injured renal tubular epithelial cells and capillary endothelial cells, as documented in both human (11, 12) and several animal models of renal diseases (13) (14) (15) (16) . Within 1 d after renal I/R injury, CD44 expression is observed on infiltrating leukocytes and capillary endothelial cells (17) .
I/R injury is characterized by a massive influx of neutrophils early after reperfusion, which exert a crucial role in the pathophysiology of postischemic renal failure by the release of cytotoxic proteases and oxygen-derived radicals (18) . Attraction of neutrophils to the postischemic tissue is regulated by endothelial adhesion molecules, complement components such as C5a, and a number of chemokines such as IL-8 (murine homologue is keratinocyte-derived chemokine [KC] ) and macrophage inflammatory protein-2 (MIP-2). We hypothesized that CD44 plays a major role in the massive influx of neutrophils and the subsequent damage to the renal tissue after I/R.
Here we report that CD44 significantly contributes to the migration of neutrophils into the postischemic renal tissue and to the development of renal damage and subsequent renal failure. We describe a novel mechanism in which CD44 expressed on endothelial cells interacts with HA on neutrophils, leading to recruitment of neutrophils to the site of inflammation. In addition, we show that disruption of CD44 -HA inter-actions is effective and offers a new therapeutic target for prevention of I/R injury.
Materials and Methods

Mice and Experimental Protocol
Bilateral ischemia or sham surgery was performed under general anesthesia (0.07 ml/10 g mouse of FFM mixture, containing 1.25 mg/ml midazolam [Roche, Mijdrecht, The Netherlands], 0.08 mg/ml fentanyl citrate, and 2.5 mg/ml fluanisone [Janssen Pharmaceutica, Beerse, Belgium]) in 6-to 8-wk-old male mice. CD44 knockout on C57Bl/6 background (CD44 Ϫ/Ϫ ) (19) and C57Bl/6 wild-type (CD44 ϩ/ϩ ) mice were bred in our animal facility. Antibody-treated mice received 16 h before surgery a single intraperitoneal injection of 100 g of anti-CD44 mAb (6, 20) 
Histology, Immunohistochemistry, and Renal Function
Renal tissues were fixed in 10% formalin for 12 h and embedded in paraffin. Sections were cut, deparaffinized, diastase treated, and stained with periodic acid-Schiff. For immunostaining, specific antibodies were used: CD44 (clone IM7.8.1), macrophages (F4/80; Serotec, Oxford, UK), neutrophils (Ly6-G; Pharmingen, Erembodegem, Belgium), and HA (biotinylated HA-binding protein; Calbiochem). As a negative control, we used species-and isotype-matched antibodies. Serum urea and serum creatinine were determined using a standard diagnostic procedures.
Histopathologic Scoring
Tubular injury, characterized by necrosis, dilation, cast deposition, and loss of brush border, was graded to the extent of corticomedullary region involvement in 10 randomly chosen, nonoverlapping fields (ϫ100 magnification), on a scale from 0 to 5: 0 ϭ normal; 1 ϭ very mild, involvement of Ͻ10% of the field; 2 ϭ mild, 10 to 25%; 3 ϭ moderate, 25 to 50%; 4 ϭ severe damage, 50 to 75%; 5 ϭ extensive damage, Ͼ75% of the field. Neutrophils and macrophages were counted in a randomly chosen nonoverlapping total of 10 fields (ϫ100 magnification; data are expressed per mm 2 ). An area of 10 mm 2 was analyzed for HA using a digital image analysis program (Image Pro-Plus, Mediacybernetics, Gleichen, Germany); results are expressed as a percentage of the analyzed corticomedullary region.
Cytokine and Chemokine ELISA
The cytokines MIP-2, KC, and IL-1␤ were measured in renal homogenates as described previously (13) by specific ELISA according to the manufacturer's instructions (R&D Systems, Minneapolis, MN).
Adoptive Transfer of Labeled Murine Neutrophils
Heparin blood was withdrawn from CD44 ϩ/ϩ and CD44 Ϫ/Ϫ mice by intracardiac puncture with a 22-G needle. Erythrocytes were subjected to hypotonic lysis. The leukocytes then were resuspended in PBS to a count of 5 ϫ 10 6 cells/ml and incubated at 37°C with 0. 
Endothelial Cells
Human umbilical vein endothelial cells (HUVEC) were isolated from human umbilical cord veins as described (23) . Cells were cultured in RPMI 1640 supplemented with 20% (vol/vol) human serum, 200 g/ml penicillin, and streptomycin (Life Technologies, Breda, The Netherlands) until confluence in 5 to 7 d. Rolling experiments under flow conditions were performed with endothelial cells of the second or third passage. HUVEC monolayers were activated by TNF-␣ (100 U/ml, 6 h, 37°C) before the rolling experiments.
Neutrophil Isolation and Pretreatment in Rolling Assays
Human neutrophils were isolated using Ficoll-Paque (Amersham Pharmacia Biotech, Freiburg, Germany), according to the manufacturer's instructions. Erythrocytes were subjected to hypotonic lysis. The HA-binding site of CD44 on endothelial cells was blocked using anti-CD44, clone BU75 (Ancell, Bayport, MN), which is reported to specifically inhibit HA binding to CD44 (24) . As control, a matched mouse IgG 2a was used (clone RPC 5; Ancell). For removing HA from the cellular surface of neutrophils, neutrophils were incubated in a phosphate-buffered solution (pH 7.0) that contained 300 g/ml hyaluronidase type IV-s (Sigma) for 10 min. Control cells were incubated in the identical buffer without hyaluronidase.
Perfusion experiments were performed as described previously (25) . In short, 1 million neutrophils were perfused through a HUVEC monolayer-containing chamber. Video images were analyzed using the image analysis software Optimas 6.1 (Media Cybernetics Systems, Silver Spring, MD). Approximately 200 neutrophils, in contact with the HUVEC, were analyzed. The results were obtained using blood of three different healthy controls in three independent experiments.
Statistical Analyses
All data were analyzed by unpaired t test comparison. Multiple comparisons were performed using a repeated measures ANOVA corrected by a Bonferroni post hoc test.
Results
Renal CD44 Expression after I/R Injury
One day after I/R, CD44 expression was detected on peritubular endothelium and infiltrating cells in the interstitium (Figure 1A) . Three, 7, and 14 d (Figure 1 , B and C) after I/R, CD44 expression increased further, and, besides leukocytes and endothelial cells, CD44 was detected laterally on tubular epithelial cells in the corticomedullary region. In sham-operated mice, renal CD44 expression was restricted to passenger leukocytes ( Figure 1D ).
CD44 Deficiency Preserved Renal Function and Decreased Renal Injury
To study the role of CD44 in I/R injury, we subjected CD44 ϩ/ϩ and CD44 Ϫ/Ϫ to bilateral I/R and compared renal function. Twenty-four hours after I/R, the increase in serum creatinine and urea levels was significantly prevented in 
CD44 Deficiency Diminished Neutrophil and Macrophage Infiltration
Because neutrophils exert a crucial role in the development of postischemic renal injury, we evaluated their influx in CD44 ϩ/ϩ and CD44 Ϫ/Ϫ after I/R. As described previously (19) , comparison of peripheral blood leukocytes revealed no differences in total leukocyte (P Ͼ 0.6), neutrophil (P Ͼ 0.9), lymphocyte (P Ͼ 0.5), or monocyte (P Ͼ 0.8) counts between CD44 ϩ/ϩ and CD44 Ϫ/Ϫ . As illustrated in Figure 3A ( Figure 3B ). To determine whether the difference in influx of neutrophils was mediated through differences in expression of chemokine/cytokine levels, we assessed homogenates of CD44 ϩ/ϩ and CD44 Ϫ/Ϫ postischemic kidneys for KC, MIP-2, and IL-1␤ ( Figure 4 ). Although KC, MIP-2, and IL-1␤ levels were elevated at days 1 and 3 after ischemia, no differences between CD44 ϩ/ϩ and CD44 Ϫ/Ϫ that could explain the re- 
HA and Osteopontin Expression in CD44
Ϫ/Ϫ and CD44
Because HA is one of the principal ligands of CD44 and promotes inflammation, we analyzed HA expression in postischemic kidneys by immunohistochemistry. Interstitial HApositive areas expanded in the postischemic kidneys of both genotypes ( Figure 5A ). Initially and at days 1 and 3 after I/R, no significant difference in HA expression was detected between CD44
ϩ/ϩ and CD44 Ϫ/Ϫ , yet clearance of HA fragments was reduced in CD44 Ϫ/Ϫ at days 7 and 14 after I/R.
Expression of the second major ligand of CD44, osteopontin, was increased after I/R injury ( Figure 5B ). However, no differences in osteopontin expression were observed between CD44 ϩ/ϩ and CD44 Ϫ/Ϫ .
Neutrophil Influx Is Mediated by Renal CD44 Rather Than Neutrophil CD44
To determine whether neutrophil bound CD44 or renal CD44 mediated neutrophil influx into the postischemic tissue, we performed adoptive transfer of neutrophils. A mixture of labeled CD44
ϩ/ϩ and CD44 Ϫ/Ϫ neutrophils was injected into recipient mice. Adoptive transfer of CD44 ϩ/ϩ and CD44
Ϫ/Ϫ neutrophils in CD44 ϩ/ϩ recipients revealed no differences in migration of neutrophils into the postischemic kidney ( Figure  6 ). In contrast, migration of both CD44 ϩ/ϩ and CD44 Ϫ/Ϫ neutrophils was impaired in CD44 Ϫ/Ϫ postischemic kidneys compared with CD44 ϩ/ϩ in relative ( Figure 6A ) as well as in absolute quantifications ( Figure 6B ). This suggested that interaction of CD44 expressed by postischemic renal cells mediated adhesion and migration of neutrophils. No circulating labeled neutrophils could be detected after 24 h of reperfusion in the blood. As shown in Figure 1A , CD44 is rapidly upregulated on peritubular capillary endothelial cells. Therefore, it is most likely that endothelial CD44 mediates neutrophil influx into the postischemic kidneys.
HA Is Expressed by Neutrophils
We evaluated potential expression of CD44 ligands by neutrophils. Flow cytometric analysis revealed membrane-bound HA, the major CD44 ligand, on murine neutrophils. Pretreatment of the neutrophils with hyaluronidase reduced binding of the HA-binding protein ( Figure 7A) . No difference could be detected in expression of HA on CD44 ϩ/ϩ and CD44 Ϫ/Ϫ neutrophils (data not shown). In addition, HA expression was detected on human neutrophils, which could be fully degraded by hyaluronidase pretreatment ( Figure 7B ). Whole-blood activation with fmlp led to a dose-dependent upregulation of HA on neutrophils ( Figure 7C ).
Endothelial CD44 and Neutrophil HA Are Involved in Rolling and Adhesion of Neutrophils
Our data strongly suggest that neutrophil extravasation into postischemic kidneys occurs through the interaction of HA on neutrophils ( Figure 7 ) and CD44 on endothelial cells ( Figures  1A and 6 ). To confirm these findings, we performed rolling assays under flow conditions with neutrophils on HUVEC. Blocking endothelial CD44 with an anti-CD44 that specifically inhibits HA binding (24) 
Blockade of CD44 -HA Interactions Reduced Neutrophil Influx and Subsequently Protected Renal Function
Administration of an antibody that interacts with the HAbinding site of CD44 (21) and may induce shedding of CD44 (22) decreased neutrophil migration into the postischemic kidney ( Figure 9A) . Injection of the antibody did not alter peripheral blood leukocyte numbers (P Ͼ 0.6) or neutrophil (P Ͼ 0.3), lymphocyte (P Ͼ 0.4), or monocyte (P Ͼ 0.2) counts. In accordance with neutrophil influx, renal function, as determined by serum creatinine and urea, was protected in anti-CD44 -treated animals compared with the control antibody-treated animals ( Figure 9B ).
Discussion
It has generally been recognized that massive influx of neutrophils is a major mediator in the development of postischemic renal failure through the release of cytotoxic proteases and oxygen-derived radicals. In this study, we show that CD44 exerts a crucial role in the migration of neutrophils into the postischemic tissue. CD44 deficiency or CD44 blockade was shown to decrease neutrophil influx, reduce renal injury, and preserve renal function.
First, we show that CD44 is rapidly upregulated in postischemic kidneys. Early after I/R injury, its expression is found predominantly on infiltrating leukocytes and capillary endothelial cells, as described earlier by Lewington et al. (17) . After 3 d of I/R injury, CD44 expression is also found laterally on tubular epithelial cells, which is in agreement with previous studies reporting CD44 expression in various models of kidney diseases (13-16) and human nephropathies (11, 12) .
Second, we demonstrate that lack of CD44 decreases renal injury after I/R and preserves renal function. I/R injury is characterized by the influx of neutrophils into the postischemic tissue, exerting a deleterious role in the pathophysiology of postischemic renal failure by the release of cytotoxic proteases and oxygen-derived radicals (18) . In accordance, depletion of neutrophils decreased renal injury (26) . In our model, we observed a Ͼ50% decrease in neutrophil influx in CD44-deficient mice. These data are in contrast with other animal models, including tuberculosis (27, 28) , Escherichia coli pneumonia (29), and bleomycin-induced pulmonary fibrosis (30) , in which CD44 deficiency leads to increased neutrophil levels. This suggests that different pathogenic mechanisms in these pulmonary diseases are at play. In the lungs, resident alveolar macrophages seem to be the major source of cytokines and chemokines. Furthermore, the model of I/R is an acute type of injury in which the infiltration of neutrophils is limited to 1 d, in contrast to the models of chronic pulmonary injury. Three and 7 d after I/R, most neutrophils are cleared from the injured kidneys in CD44 ϩ/ϩ mice, as expected from the literature. In contrast, the resolution of inflammation in the CD44 Ϫ/Ϫ postischemic kidney is delayed probably as a consequence of reduced macrophage influx, impaired clearance of inflammatory cell remnants (31) , and decreased apoptosis of neutrophils (32) in the absence of CD44. After I/R, the number of neutrophils is 30-fold higher than the number of macrophages, suggesting a relatively small contribution for macrophages in renal I/R injury. Furthermore, the differences in macrophage presence in CD44 ϩ/ϩ and CD44 Ϫ/Ϫ are unlikely to exert great impact on development of renal damage and recovery of renal function (33) . Furthermore, Teder et al. (30) described that resolution of inflammation is impaired in the absence of CD44 as a result of reduced HA clearance. Our data are in agreement with these findings. Because HA has well-known proinflammatory properties, impaired clearance of HA therefore may account for the higher numbers of neutrophils found at days 3 and 7 in the CD44 Ϫ/Ϫ postischemic kidneys.
The second CD44 ligand, osteopontin, is a chemotactic factor for macrophages (10) . Although in our study osteopontin expression in CD44 ϩ/ϩ and CD44 Ϫ/Ϫ was comparable after I/R, abrogation of osteopontin-CD44 signaling may be responsible for reduced influx of macrophages in CD44 Ϫ/Ϫ after I/R (33).
Third, to elucidate the mechanisms underlying the significant reduction in neutrophil influx after I/R, we measured cytokine and chemokine levels in postischemic kidneys. Indeed, a vari- In agreement with previous studies, we detected upregulation of KC, MIP-2, and IL-1␤ after I/R, but no differences between CD44 ϩ/ϩ and CD44 Ϫ/Ϫ that could explain the differences in neutrophil influx were observed. Therefore, we hypothesized that CD44 may play a direct role in attraction, adhesion, or migration of neutrophils. DeGrendele et al. (36, 37) showed that extravasation of lymphocytes from the blood into the vascular wall is dependent on interactions of CD44 on the cell surface of lymphocytes (7, 36, 38) , with HA on the endothelial cell surface bound to receptor for hyaluronan-mediated motility (RHAMM) (39) or CD44 (40) . To test whether this mechanism may be at play in renal I/R, we performed adoptive transfer of CD44 ϩ/ϩ and CD44 Ϫ/Ϫ neutrophils before I/R. In contrast to the mechanism proposed by DeGrendele et al. (36, 37) for lymphocytes, it was not neutrophil-bound CD44 that mediated migration of leukocytes into the postischemic tissue but renal expression of CD44, most likely by postischemic renal capillary endothelial cells. These results underline the differences between migration of lymphoid cells and neutrophils. Khan et al. (41) observed in chimeric mice, after intrascrotal injection of MIP-2, that CD44 on the endothelium as well as on the neutrophil was required to obtain optimal neutrophil emigration. This observation may . Anti-CD44 mAb protects renal function after I/R. CD44 ϩ/ϩ received before I/R an injection of anti-CD44 (f) or control (Ⅺ) antibody. Neutrophil influx and renal function were determined 1 d after I/R. Influx of neutrophils was decreased after administration of anti-CD44 (A), and renal function was preserved by administration of anti-CD44, as determined by serum creatinine and urea (B). Data are presented as mean Ϯ SEM; n ϭ 8.
be tissue specific, because disruption of CD44 leads to increased emigration of neutrophils in several pulmonary models, e.g., tuberculosis (28) , E. coli-induced pneumonia (29) , and bleomycin-induced pulmonary fibrosis (30) , and in arthritis emigration of neutrophils is CD44 independent (42) . The involvement of CD44 in migration of neutrophils in extracellular matrix may vary according to the components of the matrix, for example, HA contents (29) . The demonstration of HA at the cell surface of murine neutrophils is an important new finding of our study. Although HA is the major ligand of CD44, we could not detect differences in expression of HA on CD44 ϩ/ϩ and CD44
neutrophils. This suggests that HA is presented on the cell surface of neutrophils by non-CD44-dependent HA binding molecules, such as RHAMM (39) . The finding that HA is also expressed on human neutrophils suggests an interspecies conserved mechanism. Neutrophil activation by fmlp stimulation but not LPS could increase the expression of HA on the cellular surface of neutrophils in a dose-dependent manner. This suggests a specific mechanism leading to upregulation of HA after neutrophil activation, thereby facilitating rolling and subsequent adhesion of neutrophils. Altogether, our data suggest that interaction between endothelial CD44 and neutrophil HA plays a major role in extravasation of neutrophils into postischemic kidneys. Rolling experiments with TNF-␣-stimulated endothelial cells confirmed the important role of endothelial CD44 and neutrophil HA in the rolling of neutrophils. In fact, either blocking the HA-binding domain of CD44 on endothelial cells or removal of HA from the neutrophils decreased rolling of these neutrophils by Ͼ50%. The study of Khan et al. (41) showed that rolling of leukocytes in vivo was not impaired in the absence of CD44. This suggests that CD44 plays a specific role in the rolling of neutrophils (10 to 25% of the total number of leukocytes in mice). The effect of CD44 may remain unnoticed when analyzed in an unfractionated pool of leukocytes (75 to 90% are monocytes and/or lymphocytes). The transition of rolling to adhesion is dependent on the time when the endothelial cell and neutrophil interact (43) . In the performed perfusion experiments, disruption of the interaction between endothelial CD44 and neutrophil HA increased rolling velocity of neutrophils by Ͼ200%. Decreased numbers of rolling cells and increased rolling velocity resulted in adherence of fewer neutrophils (30%) to the endothelium. Using chimeric mice, Khan et al. (41) also showed that adhesion of neutrophils is dependent on endothelial CD44 rather than on neutrophil CD44.
Finally, we postulated that in the normal situation, neutrophils stay clear from the endothelium that is negative for CD44 and remain in the circulation. The de novo expression of CD44 on the capillary endothelial cells upon I/R mediates neutrophil adhesion by interaction with neutrophil-bound HA. Activation of neutrophils leads to increased presentation of HA, thereby increasing the interaction with endothelial CD44. The CD44 -HA interaction results in a massive infiltration of neutrophils into the injured renal tissue.
To determine whether our results could be valid for therapeutic application and to exclude adaptive mechanisms in CD44
Ϫ/Ϫ , we confirmed our results using an antibody that binds to the HA-binding region of CD44 (21) and may induce shedding of CD44 (22) . Administration of the antibody to mice before ischemia resulted in a dramatic reduction of neutrophil influx into the postischemic kidney, diminished renal damage, and preserved renal function.
In conclusion, upregulation of CD44 on capillary endothelial cells after I/R injury results in the recruitment of neutrophils into the postischemic tissue through interactions with HA at the surface of neutrophils. CD44 deficiency or inhibition of CD44 -HA ligation resulted in decreased influx of neutrophils and subsequent preservation of renal function. Therefore, targeting CD44 -HA interactions may be an innovative and efficient therapy to prevent or reduce I/R related injury.
